- All sections
- C - Chemistry; metallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 309/30 - Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups
Patent holdings for IPC class C07C 309/30
Total number of patents in this class: 264
10-year publication summary
30
|
25
|
22
|
30
|
26
|
30
|
31
|
12
|
16
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Intra-Cellular Therapies, Inc. | 393 |
10 |
Journey Medical Corporation | 93 |
7 |
Merck Sharp & Dohme LLC | 3751 |
7 |
BASF SE | 20432 |
5 |
ChemoCentryx, Inc. | 393 |
5 |
Gilead Sciences, Inc. | 1951 |
5 |
Imago Biosciences, Inc. | 37 |
5 |
Shionogi & Co., Ltd. | 889 |
5 |
WisTa Laboratories Ltd. | 125 |
5 |
Shin-Etsu Chemical Co., Ltd. | 5446 |
4 |
Advansix Resins & Chemicals LLC | 280 |
4 |
Apotex Inc. | 206 |
4 |
Pharmatrophix, Inc. | 22 |
4 |
Purdue Pharma L.P. | 512 |
4 |
Teva Pharmaceuticals International GmbH | 382 |
4 |
Eidos Therapeutics, Inc. | 15 |
4 |
Evonik Oxeno GmbH & Co. KG | 304 |
4 |
Bristol-myers Squibb Company | 4863 |
3 |
Merck Patent GmbH | 5842 |
3 |
Uop LLC | 4188 |
3 |
Other owners | 169 |